1. Aberrant miRNA promoter methylation and EMT-involving miRNAs in breast cancer metastasis: Diagnosis and therapeutic implications
   Maryam Zare et al, 2017, J Cell Physiol CrossRef
2. Bioinformatic Studies to Predict MicroRNAs with the Potential of Uncoupling RECK Expression from epithelial–mesenchymal Transition in Cancer Cells
   Zhipeng Wang et al, 2016, Cancer Informatics CrossRef
3. MiR-138-5p targeting LIMK1 suppresses breast cancer cell proliferation and motility
   Dengfeng Li et al, 2017, RSC Adv. CrossRef
4. MiR-519d-3p suppresses breast cancer cell growth and motility via targeting LIM domain kinase 1
   Dengfeng Li et al, 2017, Mol Cell Biochem CrossRef
5. MicroRNA-96 Regulates Apoptosis by Targeting PDCD4 in Human Glioma Cells
   Qing-qing Ma et al, 2017, Technol Cancer Res Treat CrossRef
6. Identification and characterization of miR-96, a potential biomarker of NSCLC, through bioinformatic analysis
   Tonghui Cai et al, 2017 CrossRef
7. microRNA-96 regulates the proliferation of nucleus pulposus cells by targeting ARID2/AKT signaling
   Bo Tao et al, 2017 CrossRef
8. Low expression of microRNA-30c promotes invasion by inducing epithelial mesenchymal transition in non-small cell lung cancer
   ZHAOPENG ZHONG et al, 2014 CrossRef
9. ZO-1 expression is suppressed by GM-CSF via miR-96/ERG in brain microvascular endothelial cells
   Hu Zhang et al, 2018, J Cereb Blood Flow Metab CrossRef
10. Expression of miRNAs Targeting mTOR and S6K1 Genes of mTOR Signaling Pathway Including miR-96, miR-557, and miR-3182 in Triple-Negative Breast Cancer.
    Javad Razaviyan et al, 2018, Appl Biochem Biotechnol CrossRef
11. Genetic Variants in pre-miR-146a, pre-miR-499, pre-miR-125a, pre-miR-605, and pri-miR-182 Are Associated with Breast Cancer Susceptibility in a South American Population
    Sebastián Morales et al, 2018, Genes CrossRef
12. Stabilization of miRNAs in esophageal cancer contributes to radioresistance and limits efficacy of therapy.
    Akshay Malhotra et al, 2019, Biochimie CrossRef
13. MicroRNA-96 Promotes Schistosomiasis Hepatic Fibrosis in Mice by Suppressing Smad7
    Xufeng Luo et al, 2018, Molecular Therapy - Methods & Clinical Development CrossRef
14. Long non-coding RNA MEG3 suppresses the development of bladder urothelial carcinoma by regulating miR-96 and TPM1
    Guanghua Liu et al, 2018, Cancer Biology & Therapy CrossRef
15. Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson’s disease
    Yue Dong et al, 2018, Mol Med CrossRef
16. The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis
    Mahsa Javadian et al, 2018, J Cell Physiol CrossRef
17. 3D Mammary Epithelial Cell Models: A Goldmine of DCIS Biomarkers and Morphogenetic Mechanisms
    Stefano Rossetti et al, 2019, Cancers CrossRef
18. The role of miRNAs as a predictor of multicentricity in breast cancer
    Huseyin Akbulut et al, 2019, Mol Biol Rep CrossRef
19. MALAT1 knockdown inhibits proliferation and enhances cytarabine chemosensitivity by upregulating miR-96 in acute myeloid leukemia cells
    Ning Hu et al, 2019, Biomedicine & Pharmacotherapy CrossRef
20. Local microRNA delivery targets Palladin and prevents metastatic breast cancer
    Avital Gilam et al, 2016, Nat Commun CrossRef
21. null
    Anne E. Sarver et al, 2015 CrossRef
22. FOXO1 3′UTR functions as a ceRNA in repressing the metastases of breast cancer cells via regulating miRNA activity
    Jue Yang et al, 2014 CrossRef
23. MiR-96 promotes proliferation and chemo- or radioresistance by down-regulating RECK in esophageal cancer
    Haifeng Xia et al, 2014, Biomedicine & Pharmacotherapy CrossRef
24. Breast tissue–based microRNA panel highlights microRNA-23a and selected target genes as putative biomarkers for breast cancer
    Sanaa Eissa et al, 2015, Translational Research CrossRef
25. miR-96 promotes osteogenic differentiation by suppressing HBEGF-EGFR signaling in osteoblastic cells
    Mingfu Yang et al, 2014 CrossRef
26. microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer
    Jen N. Goh et al, 2016, Biol Rev CrossRef
27. MiR-32 contributed to cell proliferation of human breast cancer cells by suppressing of PHLPP2 expression
    Haoming Xia et al, 2015, Biomedicine & Pharmacotherapy CrossRef
28. miR-96 suppresses renal cell carcinoma invasion via downregulation of Ezrin expression
    Nengwang Yu et al, 2015, J Exp Clin Cancer Res CrossRef
29. Upregulation of microRNA-96 and its oncogenic functions by targeting CDKN1A in bladder cancer.
    Ziyu Wu et al, 0 CrossRef
30. Construction of an initial microRNA regulation network in breast invasive carcinoma by bioinformatics analysis
    Yongjia Yin et al, 2016, The Breast CrossRef
31. Noncoding RNAs in breast cancer
    Pang-Kuo Lo et al, 2016, Briefings in Functional Genomics CrossRef
32. Identification of direct target genes of miR-7, miR-9, miR-96, and miR-182 in the human breast cancer cell lines MCF-7 and MDA-MB-231
    Hamidreza Moazzeni et al, 2017, Molecular and Cellular Probes CrossRef
33. Promotion of tumour proliferation, migration and invasion by miR-92b in targeting RECK in osteosarcoma
    Zhenhua Zhou et al, 2016 CrossRef
34. Dysregulation and functional roles of miR-183-96-182 cluster in cancer cell proliferation, invasion and metastasis
    Yi Ma et al, 2106, Oncotarget CrossRef
35. The microRNAs miR-200b-3p and miR-429-5p target the LIMK1/CFL1 pathway to inhibit growth and motility of breast cancer cells
    Dengfeng Li et al, 2017, Oncotarget CrossRef
36. Oncogenic miR-96-5p inhibits apoptosis by targeting the caspase-9 gene in hepatocellular carcinoma.
    Naoto Iwai et al, 0 CrossRef
37. Long non-coding RNA CASC2 inhibits breast cancer cell growth and metastasis through the regulation of the miR-96-5p/SYVN1 pathway.
    Zejun Gao et al, 0 CrossRef
38. Correlation between CT features of adrenocortical and adrenal medullary tumors and expression of miR‑96 in serum
    Yongyun Xu et al, 2018, Oncol Lett CrossRef
39. MicroRNA‑96 expression induced by low‑dose cisplatin or doxorubicin regulates chemosensitivity, cell death and proliferation in gastric cancer SGC7901 cells by targeting FOXO1
    Chunhui Lang et al, 2018, Oncol Lett CrossRef
40. miR‑496, miR‑1185, miR‑654, miR‑3183 and miR‑495 are downregulated in colorectal cancer cells and have putative roles in the mTOR pathway
    Naif Alqurashi et al, 2019, Oncol Lett CrossRef
41. Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals
    Seung Wan Son et al, 2020, Molecules CrossRef
42. Identification and Functional Validation of Reciprocal microRNA–mRNA Pairings in African American Prostate Cancer Disparities
    Bi-Dar Wang et al, 2015, Clin Cancer Res CrossRef
43. MiR-19a/miR-96-mediated low expression of KIF26A suppresses metastasis by regulating FAK pathway in gastric cancer
    Ran-Ran Ma et al, 2021, Oncogene CrossRef
44. Identification of microRNA‐96‐5p as a postoperative, prognostic microRNA predictor in nonviral hepatocellular carcinoma
    Takeshi Matsui et al, 2021, Hepatology Research CrossRef
45. The role of non-coding RNAs in chemotherapy for gastrointestinal cancers
    Fatemeh Dashti et al, 2021, Molecular Therapy - Nucleic Acids CrossRef
46. Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review
    Ahmed Ismail et al, 2022, International Journal of Biological Macromolecules CrossRef
47. miR-96 and its versatile role in cancer
    Mohammedazim Bagban et al, 2022, Advances in Cancer Biology - Metastasis CrossRef
48. Microrna-96 In Human Cancers
    Yiwen Wu et al, 2023, CCHTS CrossRef